Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Summary of Antidilutive Securities Excluded from Computation of Weighted Average Common Stock Outstanding

The following potentially dilutive shares of common stock have not been included in the computation of diluted net loss per share for the three months ended March 31, 2020 and 2019, as the result would be anti-dilutive:

 

Three Months Ended March 31,

 

 

2020

 

 

2019

 

Warrants to purchase Series C-1 Preferred

 

 

 

 

14,033

 

Warrants to purchase common stock associated with Solar loan agreement

 

122,435

 

 

 

122,435

 

Warrants to purchase common stock associated with June 2016 public offering

 

4,218,750

 

 

 

4,218,750

 

Warrants to purchase common stock associated with March 2018 public offering – Series 2

 

7,988,175

 

 

 

7,988,175

 

Outstanding stock options

 

7,684,762

 

 

 

5,310,498

 

Outstanding restricted stock units

 

862,514

 

 

 

107,841

 

Common stock associated with 6% convertible senior notes

 

11,382,000

 

 

 

13,008,000

 

Warrants to purchase common stock associated with December 2019 Public Offering

 

44,722,222

 

 

 

 

Total

 

76,980,858

 

 

 

30,769,732